BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parimon T, Hohmann MS, Yao C. Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis. Int J Mol Sci 2021;22:6214. [PMID: 34207528 DOI: 10.3390/ijms22126214] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Pan L, Meng F, Wang W, Wang XH, Shen H, Bao P, Kang J, Kong D. Nintedanib in an elderly non-small-cell lung cancer patient with severe steroid-refractory checkpoint inhibitor-related pneumonitis: A case report and literature review. Front Immunol 2022;13:1072612. [PMID: 36703957 DOI: 10.3389/fimmu.2022.1072612] [Reference Citation Analysis]
2 Ligresti G, Raslan AA, Hong J, Caporarello N, Confalonieri M, Huang SK. Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis. Gene 2023;859:147142. [PMID: 36603696 DOI: 10.1016/j.gene.2022.147142] [Reference Citation Analysis]
3 Li RJ, Wu CY, Ke HL, Wang XP, Zhang YW. Qing Fei Hua Xian Decoction ameliorates bleomycin-induced pulmonary fibrosis by suppressing oxidative stress through balancing ACE-AngII-AT1R/ACE2-Ang-(1-7)-Mas axis. Iran J Basic Med Sci 2023;26:107-13. [PMID: 36594067 DOI: 10.22038/IJBMS.2022.67042.14700] [Reference Citation Analysis]
4 Pantzke J, Offer S, Zimmermann EJ, Kuhn E, Streibel T, Oeder S, Di Bucchianico S, Zimmermann R. An alternative in vitro model considering cell-cell interactions in fiber-induced pulmonary fibrosis. Toxicology Mechanisms and Methods 2022. [DOI: 10.1080/15376516.2022.2156008] [Reference Citation Analysis]
5 Xiong J, Duan J, Jiang N, Zhang C, Zhong W, Yang J, Liu Y, Su F, Zhou Y, Li D, Yang H, Guan C. TREM-1 exacerbates bleomycin-induced pulmonary fibrosis by aggravating alveolar epithelial cell senescence in mice. International Immunopharmacology 2022;113:109339. [DOI: 10.1016/j.intimp.2022.109339] [Reference Citation Analysis]
6 Zhang T, Zhang J, Lv C, Li H, Song X. Senescent AECⅡ and the implication for idiopathic pulmonary fibrosis treatment. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1059434] [Reference Citation Analysis]
7 Zhou S, Zhu J, Zhou PK, Gu Y. Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis. Front Cell Dev Biol 2022;10:999600. [PMID: 36407111 DOI: 10.3389/fcell.2022.999600] [Reference Citation Analysis]
8 Abedini A, Ma Z, Frederick J, Dhillon P, Balzer MS, Shrestha R, Liu H, Vitale S, Devalaraja-narashimha K, Grandi P, Bhattacharyya T, Hu E, Pullen SS, Boustany-kari CM, Guarnieri P, Karihaloo A, Yan H, Coleman K, Palmer M, Sarov-blat L, Morton L, Hunter CA, Li M, Susztak K. Spatially resolved human kidney multi-omics single cell atlas highlights the key role of the fibrotic microenvironment in kidney disease progression.. [DOI: 10.1101/2022.10.24.513598] [Reference Citation Analysis]
9 Onorati A, Havas AP, Lin B, Rajagopal J, Sen P, Adams PD, Dou Z. Upregulation of PD-L1 in Senescence and Aging. Mol Cell Biol 2022;42:e0017122. [PMID: 36154662 DOI: 10.1128/mcb.00171-22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lv K, Wang Y, Lou P, Liu S, Zhou P, Yang L, Lu Y, Cheng J, Liu J. Extracellular vesicles as advanced therapeutics for the resolution of organ fibrosis: Current progress and future perspectives. Front Immunol 2022;13:1042983. [DOI: 10.3389/fimmu.2022.1042983] [Reference Citation Analysis]
11 Guo L, Bai S, Ding S, Zhao L, Xu S, Wang X, Yang X. PM2.5 Exposure Induces Lung Injury and Fibrosis by Regulating Ferroptosis via TGF-β Signaling. Disease Markers 2022;2022:1-11. [DOI: 10.1155/2022/7098463] [Reference Citation Analysis]
12 Deinhardt-emmer S, Le Saux CJ. The Aging Microenvironment in Lung Fibrosis. Curr Tissue Microenviron Rep 2022;3:67-76. [DOI: 10.1007/s43152-022-00038-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Tsou PS, Shi B, Varga J. Role of cellular senescence in the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 2022. [PMID: 35979691 DOI: 10.1097/BOR.0000000000000898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sinha S, Castillo V, Espinoza CR, Tindle C, Fonseca AG, Dan JM, Katkar GD, Das S, Sahoo D, Ghosh P. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis. EBioMedicine 2022;82:104185. [PMID: 35870428 DOI: 10.1016/j.ebiom.2022.104185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 He X, Jarrell ZR, Liang Y, Ryan Smith M, Orr ML, Marts L, Go YM, Jones DP. Vanadium pentoxide induced oxidative stress and cellular senescence in human lung fibroblasts. Redox Biol 2022;55:102409. [PMID: 35870339 DOI: 10.1016/j.redox.2022.102409] [Reference Citation Analysis]
16 Matsui Y, Kadoya K, Nagano Y, Endo T, Hara M, Matsumae G, Suzuki T, Yamamoto Y, Terkawi MA, Iwasaki N. IL4 stimulated macrophages promote axon regeneration after peripheral nerve injury by secreting uPA to stimulate uPAR upregulated in injured axons. Cell Mol Life Sci 2022;79:289. [PMID: 35536429 DOI: 10.1007/s00018-022-04310-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 M’kacher R, Jaillet M, Colicchio B, Vasarmidi E, Mailleux A, Dieterlen A, Kannengiesser C, Borie C, Oudrhiri N, Junker S, Voisin P, Jeandidier E, Carde P, Fenech M, Bennaceur-griscelli A, Crestani B, Borie R. Lung Fibroblasts from Idiopathic Pulmonary Fibrosis Patients Harbor Short and Unstable Telomeres Leading to Chromosomal Instability. Biomedicines 2022;10:310. [DOI: 10.3390/biomedicines10020310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Wasnick RM, Shalashova I, Wilhelm J, Khadim A, Schmidt N, Hackstein H, Hecker A, Hoetzenecker K, Seeger W, Bellusci S, El Agha E, Ruppert C, Guenther A. Differential LysoTracker Uptake Defines Two Populations of Distal Epithelial Cells in Idiopathic Pulmonary Fibrosis. Cells 2022;11:235. [PMID: 35053350 DOI: 10.3390/cells11020235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Sinha S, Castillo V, Espinoza CR, Tindle C, Fonseca AG, Dan JM, Katkar GD, Das S, Sahoo D, Ghosh P. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.. [DOI: 10.1101/2021.11.28.470269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Li T, Yang XY, Xu DJ, Gao ZY, Gao YB, Jin FY, Li YQ, Liu SP, Li SF, Gao XM, Cai WC, Mao N, Wei ZQ, Liu HL, Sun Y, Yang F, Xu H. OC-STAMP Overexpression Drives Lung Alveolar Epithelial Cell Type II Senescence in Silicosis. Oxid Med Cell Longev 2021;2021:4158495. [PMID: 34426759 DOI: 10.1155/2021/4158495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]